ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 29 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $887,000 | +49.6% | 40,344 | -78.3% | 0.12% | -62.5% |
| Q3 2019 | $593,000 | -53.4% | 185,800 | -47.6% | 0.32% | -80.0% |
| Q2 2019 | $1,273,000 | -48.7% | 354,713 | -48.0% | 1.60% | +34.3% |
| Q1 2019 | $2,481,000 | -11.4% | 681,500 | -27.0% | 1.19% | +93.5% |
| Q4 2018 | $2,799,000 | -27.8% | 933,050 | +16.5% | 0.62% | +24.2% |
| Q3 2018 | $3,876,000 | +6582.8% | 801,242 | +7489.0% | 0.50% | +24700.0% |
| Q3 2015 | $58,000 | -95.2% | 10,558 | -95.0% | 0.00% | -95.5% |
| Q2 2015 | $1,204,000 | – | 212,017 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |